Sign In
Buy GMED
$86.15
+3.80 (+4.61%)
At Close: Aug 10, 2026
Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect?
10:56am, Monday, 08'th Jun 2026
The consensus price target hints at a 38.9% upside potential for Globus Medical (GMED). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings es
GMED or PEN: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 05'th Jun 2026
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and Penumbra (PEN). But which of these two companies is the best option for th
Here's Why Globus Medical (GMED) is a Strong Value Stock
10:40am, Friday, 05'th Jun 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's How Financial Strength Remains a Key Advantage for GMED
12:55pm, Thursday, 04'th Jun 2026
Globus Medical's debt-free balance sheet, nearly $630M in liquid assets and strong cash flow give it the flexibility to fund growth and support shareholders.
Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?
11:30am, Tuesday, 02'nd Jun 2026
Globus Medical is riding musculoskeletal market growth with spine, trauma and ortho gains, strong cash flow and a debt-free balance sheet.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Globus Medical, Inc. (NYSE: GMED)
09:05am, Monday, 01'st Jun 2026
NEW YORK, June 1, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Globus Medical, Inc. (NYSE: GMED) on behalf of the company's shareholders. The investigation seeks t
GMED's Robotics Leasing Shift Could Build Recurring Revenue
10:55am, Friday, 29'th May 2026
Globus Medical is shifting robotics deals to leases and rentals, aiming to expand its installed base and build recurring revenue streams.
Reasons to Retain TransMedics Stock in Your Portfolio for Now
02:01pm, Thursday, 28'th May 2026
TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.
GMED Growth Drivers After NuVasive and What Q1 Signals
10:26am, Thursday, 28'th May 2026
Globus Medical's Q1 showed margin gains, strong spine and trauma growth, and rising robotics adoption as NuVasive synergies support 2026 targets.
Looking for a Growth Stock? 3 Reasons Why Globus Medical (GMED) is a Solid Choice
01:46pm, Wednesday, 27'th May 2026
Globus Medical (GMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Globus Medical (GMED) Upgraded to Strong Buy: Here's What You Should Know
01:01pm, Wednesday, 27'th May 2026
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
3 Medical Instrument Stocks Exploring GenAI to Tackle Industry Woes
02:35pm, Thursday, 21'st May 2026
GenAI is reshaping medical instruments as Electromed, Globus Medical and Intuitive Surgical navigate M&A and market pressures.
Globus Medical Inc (GMED) Shares Surge 5.1% -- What GF Score of 97 Tells Investors
07:19pm, Wednesday, 20'th May 2026
On May 20, 2026, Globus Medical Inc (GMED) shares rose 5.1% today, reaching a current price of $84.03. The stock is trading within a 52-week range of $51.79 to
GMED vs. SONVY: Which Stock Is the Better Value Option?
12:40pm, Wednesday, 20'th May 2026
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value inve
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
10:40am, Wednesday, 20'th May 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
